- IN₹2.56bn
- IN₹1.18bn
- IN₹919.28m
- 75
- 16
- 33
- 35
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.32 | ||
| Price to Tang. Book | 1.33 | ||
| Price to Free Cashflow | 67.23 | ||
| Price to Sales | 2.69 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -7.86% | ||
| Return on Equity | -2.95% | ||
| Operating Margin | -16.43% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 994.26 | 2,134.54 | 2,555.48 | 1,113.23 | 919.28 | n/a | n/a | -1.94% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +625.16 | -3.05 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Nureca Limited is a specialist in home healthcare and wellness products. Its products serve individuals, caregivers and medical practitioners across the globe. It offers a range of products specialized in home-based, non-invasive digital diagnosis and prevention of lifestyle diseases. Its range of products are spread across categories like respiratory wellbeing, physiotherapy, cardiac health monitoring, diabetes detection, mother and childcare and more. Its brands include Dr. Trust, trumom and Dr. Physio. Dr. Trust is a wellness and healthcare brand which provides medical devices and health monitoring solutions. trumom is a mother and childcare brand. Dr. Physio is an ortho and pain management brand. Its chronic devices include home monitoring devices and medical wearables that populate readings to identify health patterns. Its lifestyle products span weighing scales to yoga gear. Dr Trust 360 enables monitoring, analyses, storing and reporting of health data and patterns over time.
Directors
- Saurabh Goyal CHM (35)
- Aryan Goyal CEO
- Nishant Garg CFO
- Chetna Anand CCO
- Gurvikram Singh OTH
- Ruchita Agarwal IND
- Nitin Bidikar IND (53)
- Vikram Chaudhery IND (34)
- Vijay Sharma IND (62)
- Charu Singh IND
- Shrikant Tamhane IND (39)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- November 2nd, 2016
- Public Since
- February 25th, 2021
- No. of Shareholders
- 46,881
- No. of Employees
- 138
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
National Stock Exchange of India- Shares in Issue
- 10,000,175
- Address
- Sco 6-7-8, CHANDIGARH, 160009
- Web
- https://www.nureca.com/
- Phone
- Contact
- Gurvikram Singh
- Auditors
- BSR & Co. LLP
Upcoming Events for NURECA
Similar to NURECA
Borosil Scientific
National Stock Exchange of India
Entero Healthcare Solutions
National Stock Exchange of India
HVAX Technologies
National Stock Exchange of India
Laxmi Dental
National Stock Exchange of India
Mohini Health & Hygiene
National Stock Exchange of India
FAQ
As of Today at 22:22 UTC, shares in Nureca are trading at IN₹255.52. This share price information is delayed by 15 minutes.
Shares in Nureca last closed at IN₹255.52 and the price had moved by -7.5% over the past 365 days. In terms of relative price strength the Nureca share price has underperformed the S&P BSE 100 Index by -14.3% over the past year.
There is no consensus recommendation for this security.
Find out moreNureca does not currently pay a dividend.
Nureca does not currently pay a dividend.
Nureca does not currently pay a dividend.
To buy shares in Nureca you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹255.52, shares in Nureca had a market capitalisation of IN₹2.56bn.
Here are the trading details for Nureca:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: NURECA
Based on an overall assessment of its quality, value and momentum Nureca is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nureca. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -12.91%.
As of the last closing price of IN₹255.52, shares in Nureca were trading -11.17% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Nureca PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹255.52.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Nureca's management team is headed by:
- Saurabh Goyal - CHM
- Aryan Goyal - CEO
- Nishant Garg - CFO
- Chetna Anand - CCO
- Gurvikram Singh - OTH
- Ruchita Agarwal - IND
- Nitin Bidikar - IND
- Vikram Chaudhery - IND
- Vijay Sharma - IND
- Charu Singh - IND
- Shrikant Tamhane - IND